银屑病症状量表、FACIT-疲劳和疼痛视觉模拟量表在泛发性脓疱型银屑病患者中的心理测量学验证
本研究利用Effisayil 1随机试验数据,评估银屑病症状量表(PSS)、FACIT-疲劳和疼痛视觉模拟量表(pain-VAS)在泛发性脓疱型银屑病(GPP)患者中的心理测量学特性。结果显示PSS和FACIT-疲劳具有单维性、内部一致性(Cronbach's α分别为0.71和0.95)、重测信度(ICC≥0.70)和聚合效度,三种量表均能区分不同症状严重程度组并检测症状变化。
要点
- PSS和FACIT-疲劳在GPP患者中显示出良好的信效度。
- 三种量表均能区分不同症状严重程度并检测变化。
- 研究基于Effisayil 1试验的GPP患者数据。
核心结论
- PSS、FACIT-疲劳和pain-VAS在GPP患者中具有良好的信度、效度和检测变化的能力。
研究设计与样本
- 基于Effisayil 1随机试验数据,对PSS、FACIT-疲劳和pain-VAS进行心理测量学验证。
主要发现
- PSS和FACIT-疲劳的条目间及条目-总分相关性多为中等或强。
- 验证性因子分析显示PSS和FACIT-疲劳具有单维性,因子载荷范围分别为0.75-0.94和0.11-0.93。
- PSS和FACIT-疲劳的Cronbach's α分别为0.71和0.95。
- 三种量表的重测信度ICC均≥0.70,并具有聚合效度。
- 三种量表能区分不同症状严重程度组(p<0.0001-0.0225)并检测第1周的症状变化(p<0.0001-0.0002)。
关键数值与推荐
- PSS的Cronbach's α为0.71,FACIT-疲劳为0.95。
- 重测信度ICC≥0.70。
- 已知组效度检验p值范围<0.0001至0.0225。
- 检测变化能力p值范围<0.0001至0.0002。
临床怎么用
- PSS、FACIT-疲劳和pain-VAS可作为GPP患者报告结局工具用于临床评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Generalized pustular psoriasis (GPP) is a rare, chronic, inflammatory skin disease associated with considerable patient burden. The Psoriasis Symptom Scale (PSS), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) and pain-Visual Analogue Scale (pain-VAS) are patient-reported outcomes (PROs) that have not yet been validated in patients with GPP. OBJECTIVES: To evaluate the psychometric properties of the PSS, FACIT-Fatigue and pain-VAS using data from Effisayil 1, a randomised trial of spesolimab in patients with moderate-to-severe GPP. METHODS: Inter-item correlations and confirmatory factor analysis (CFA) were performed using Week 1 data. Internal consistency was assessed with Cronbach's α coefficient using baseline and Week 1 data. Test-retest reliability was assessed using intraclass correlation coefficients (ICCs); change data for the GPP Physician Global Assessment total score and pustulation subscore were used to define a stable population. Convergent validity was assessed at baseline and Week 1 using Spearman's rank-order correlations. Known-groups validity was measured by analysis of variance using Week 1 data. Ability to detect change from baseline to Week 1 was evaluated by analysis of covariance. RESULTS: Inter-item and item-to-total correlations were moderate or strong for most PSS and FACIT-Fatigue items. CFA demonstrated the unidimensionality of the PSS and FACIT-Fatigue, with high factor loadings for most items (PSS range, 0.75-0.94; FACIT-Fatigue range, 0.11-0.93) and acceptable fit statistics. Both scores demonstrated internal consistency (Cronbach's α, 0.71 and 0.95, respectively). The PSS, FACIT-Fatigue and pain-VAS demonstrated test-retest reliability (ICCs ≥0.70) and good evidence of convergent validity. Furthermore, the PROs could differentiate between known groups of varying symptom severity (range, p < 0.0001-0.0225) and detect changes in symptom severity from baseline to Week 1 (range, p < 0.0001-0.0002). CONCLUSIONS: Overall, these results support the reliability, validity and ability to detect change of the PSS, FACIT-Fatigue and pain-VAS as PROs in patients with GPP.
引用
- Burden AD, Bissonnette R, Anatchkova M, et al. Psychometric validation of the Psoriasis Symptom Scale, Functional Assessment of Chronic Illness Therapy-Fatigue and pain-Visual Analogue Scale in patients with generalized pustular psoriasis. J Eur Acad Dermatol Venereol. 2024. PMID: 38334243. doi:10.1111/jdv.19830
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。